期刊文献+

13个血清型肺炎球菌荚膜多糖稳定性考察 被引量:2

Stability of pneumococcal polysaccharide of 13 serotypes
原文传递
导出
摘要 目的考察13个血清型肺炎球菌荚膜多糖在-60℃以下储存60个月的稳定性。方法将13个血清型(1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F和23F型)各3批共39批次原料多糖,-60℃以下条件储存,每隔6个月取样,分别对多糖成分基团含量、分布系数(K_D)、分子质量分布激光图谱和多糖抗原活性进行测定。检测时长为60个月。结果 60个月内39批次多糖的成分基团含量及K_D均符合质量标准;分子质量分布激光图谱并无明显变化;抗原活性良好。结论 -60℃储存条件下,13个血清型肺炎球菌原料多糖在60个月内稳定性良好。 Objective To investigate the stability of pneumococcal polysaccharide (Pn Ps) of 13 serotypes stored at -60 ℃ for 60 months. Methods Pn Ps of serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F, three batches for each, were stored at -60 ℃, from which samples were taken every 6 months and determined for composition content, distribution coefficient (K o) value, molecular weight distribution (HPSEC-MALLS/RI) and antigen activity. The total time length for determination was 60 months. Results The composition content and Ko value of pneumococcal polysaccharide stored at -60 ℃ for 60 months met the relevant quality standards. The results of HPSEC- MALLS/RI showed no significant change. The Pn Ps showed high antigen activity. Conclusion The pneumocoecal polysaceharide of 13 serotypes showed high stability after storage at -60℃for 36 months.
作者 任珍芸 刘倩 张轶 陈晓航 刘爱萍 王玺 熊明郁 沈荣 REN Zhen-yun;LIU Qian;ZHANG Yi;CHEN Xiao-hang;LIU Ai-ping;WANG Xi;XIONG Ming-yu;SHEN Rong First(Department of Research,Lanzhou Institute of Biological Products Co.,Ltd.,Center for Gansu Provincial Vaccine Engineering Research,Lanzhou 730046,Gansu Province,China)
出处 《中国生物制品学杂志》 CAS CSCD 2018年第10期1075-1083,共9页 Chinese Journal of Biologicals
基金 "十二五"国家高技术发展研究计划(863计划)疫苗研发关键技术及产品研发项目(2012AA02A401)
关键词 肺炎球菌 荚膜多糖 稳定性 有效期 Pneumococcus Pneumococcal polysaccharide Stability Validity period
  • 相关文献

参考文献4

二级参考文献27

  • 1吴凯,代泽友,马波,周燕美,吴绍学,樊会兰,黄镇.改进的蒽酮法检测肺炎链球菌荚膜多糖结合物中多糖浓度[J].中国生物制品学杂志,2007,20(7):536-538. 被引量:8
  • 2Wong K H,J Biol Stand,1977年,5卷,197页 被引量:1
  • 3Patrick R,Murray PR,Baron EJ, et al. Manual of Clinical Microbiology.Vol 1[M]. 9th ed. Washington DC:American Society for Microbiology,2007. 被引量:1
  • 4Yao KH,Yang YH. Streptococcus pneumoniae diseases in Chinese children:past,present and future[J].Vaccine,2008,26(35):4425. 被引量:1
  • 5O'Brien KL,Wolfson LJ,Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years:global estimates[J].Lancet,2009,374(9693):893. 被引量:1
  • 6Pneumococcal conjugate vaccine for childhood immunization-WHO position paper[R]. Wkly Epidemiol Rec,2007,82(12):93. 被引量:1
  • 7Miller E,Andrews N,Waight P, et al. Bacterial infections,immune overload,and MMR vaccine. Measles,mumps,and rubella[J].Arch Dis Child,2003,88(3):222. 被引量:1
  • 8Hansen J,Black S,Shinefield H, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia:updated analysis using World Health Organization standardized interpretation of chest radiographs[J].PediatrInf Dis J,2006,25(9):779. 被引量:1
  • 9MacIntyre CR,Egerton T,McCaughey M, et al. Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old[J].Hum Vaccin,2010,6(11):894. 被引量:1
  • 10Thorburn AN,O'Sullivan BJ,Thomas R, et al. Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease[J].Thorax,2010,65(12):1053. 被引量:1

共引文献12

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部